The viruses used from BrainVTA in this article are in the table below

Aging is a crucial cause of cognitive decline and a major risk factor for Alzheimer’s disease (AD); however, AD’s underlying molecular mechanisms remain unclear. Recently, tetraspanins have emerged as important modulators of synaptic function and memory. We demonstrate that the level of tetraspanin CD82 is upregulated in the brains of AD patients and middle-aged mice. In young adult mice, injection of AAV-CD82 to the hippocampus induced AD-like cognitive deficits and impairments in neuronal spine density. CD82 overexpression increased TRPM7 α-kinase cleavage via caspase-3 activation and induced Numb phosphorylation at Thr346 and Ser348 residues. CD82 overexpression promoted beta-amyloid peptide (Aβ) secretion which could be reversed by Numb T346S348 mutants. Importantly, hippocampus-related memory functions were improved in Cd82−/− mice. Taken together, our findings provide the evidence that links the elevated CD82-TRPM7-Numb signaling to age-related cognitive impairment.

Figure 1. Increased CD82 impaired behavioral and morphological changes in a young adult mouse model.

This study is aimed to explore AD’s underlying molecular mechanisms. In the present study, the authors report that CD82 levels are increased in brains of AD patients and of middle-aged mouse model. CD82 overexpression in the hippocampus impairs learning, memory, and synaptic plasticity in young adult mice. The findings strongly indicate a pathophysiological role for CD82 in the development of AD and its potential as a novel AD therapy target.

 
BrainVTA offers viral vector construction & virus packaging services for AAV, LV, RABV, PRV, HSV and VSV that help researchers explore questions about genes, neurons, circuitry structure, function of brain network, mechanism and treatment of diseases.
If you have any needs, just email us at sales@brainvta.com.